Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

NCT07257484 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT07257484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07257484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
Lead sponsor
Weill Medical College of Cornell University
Phase
Phase 4
Overall status
Recruiting
Start date
June 8, 2026
Completion date
February 25, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, obesity (disorder)